AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?

The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

Recursion Pharmaceuticals and Relay Therapeutics both leverage their respective AI drug discovery platforms to potentially develop novel therapeutic candidates.

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

Tidmarsh, MD, PhD, is to oversee the safety and effectiveness of over-the-counter and prescription drugs at the CDER.

Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

A potential target for experimental drugs that block PRMT5—a naturally occurring enzyme some tumors rely more on for survival ...

An investigation can reveal the secret history of one of Australia’s top scientists, whose faked data underpins a drug now ...

Romanian pharmaceutical company Antibiotice (BVB: ATB) plans to invest RON 376 million (approximately EUR 70 million) in a new research and development center focused on the production of critical ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...